{"id":"https://openalex.org/W2604932078","doi":"https://doi.org/10.1002/ajh.24746","title":"An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromes","display_name":"An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromes","publication_year":2017,"publication_date":"2017-04-03","ids":{"openalex":"https://openalex.org/W2604932078","doi":"https://doi.org/10.1002/ajh.24746","mag":"2604932078","pmid":"https://pubmed.ncbi.nlm.nih.gov/28370157","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5580683"},"language":"en","primary_location":{"id":"doi:10.1002/ajh.24746","doi":"https://doi.org/10.1002/ajh.24746","is_oa":true,"landing_page_url":"https://doi.org/10.1002/ajh.24746","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ajh.24746","source":{"id":"https://openalex.org/S199810014","display_name":"American Journal of Hematology","issn_l":"0361-8609","issn":["0361-8609","1096-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Hematology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ajh.24746","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066658979","display_name":"May Daher","orcid":"https://orcid.org/0000-0002-6026-8397","observed_orcids":["https://orcid.org/0000-0002-6026-8397"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"May Daher","raw_affiliation_strings":["Division of Cancer Medicine, The University of Texas M.D. Anderson Cancer Center Texas USA"],"raw_orcid":"https://orcid.org/0000-0002-6026-8397","affiliations":[{"raw_affiliation_string":"Division of Cancer Medicine, The University of Texas M.D. Anderson Cancer Center Texas USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104729483","display_name":"Juliana Elisa Hidalgo Lopez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Juliana Elisa Hidalgo Lopez","raw_affiliation_strings":["Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center Texas USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center Texas USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109359142","display_name":"Jasleen K. Randhawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jasleen K. Randhawa","raw_affiliation_strings":["Department of Leukemia, The University of Texas M.D. Anderson Cancer Center Texas USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas M.D. Anderson Cancer Center Texas USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110021992","display_name":"Kausar Jabeen Jabbar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kausar Jabeen Jabbar","raw_affiliation_strings":["Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center Texas USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center Texas USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012461067","display_name":"Yue Wei","orcid":"https://orcid.org/0000-0002-2288-8405","observed_orcids":["https://orcid.org/0000-0002-2288-8405"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yue Wei","raw_affiliation_strings":["Department of Leukemia, The University of Texas M.D. Anderson Cancer Center Texas USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas M.D. Anderson Cancer Center Texas USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088307376","display_name":"Naveen Pemmaraju","orcid":"https://orcid.org/0000-0002-1670-6513","observed_orcids":["https://orcid.org/0000-0002-1670-6513"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naveen Pemmaraju","raw_affiliation_strings":["Department of Leukemia, The University of Texas M.D. Anderson Cancer Center Texas USA"],"raw_orcid":"https://orcid.org/0000-0002-1670-6513","affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas M.D. Anderson Cancer Center Texas USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055045706","display_name":"Gautam M. Borthakur","orcid":"https://orcid.org/0000-0001-7679-6453","observed_orcids":["https://orcid.org/0000-0001-7679-6453"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gautam Borthakur","raw_affiliation_strings":["Department of Leukemia, The University of Texas M.D. Anderson Cancer Center Texas USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas M.D. Anderson Cancer Center Texas USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020340537","display_name":"Tapan Mahendra Kadia","orcid":"https://orcid.org/0000-0002-9892-9832","observed_orcids":["https://orcid.org/0000-0002-9892-9832"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tapan Kadia","raw_affiliation_strings":["Department of Leukemia, The University of Texas M.D. Anderson Cancer Center Texas USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas M.D. Anderson Cancer Center Texas USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022647201","display_name":"Marina Y Konopleva","orcid":"https://orcid.org/0000-0002-9347-2212","observed_orcids":["https://orcid.org/0000-0002-9347-2212"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marina Konopleva","raw_affiliation_strings":["Department of Leukemia, The University of Texas M.D. Anderson Cancer Center Texas USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas M.D. Anderson Cancer Center Texas USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090435894","display_name":"Hagop M. Kantarjian","orcid":"https://orcid.org/0000-0002-1908-3307","observed_orcids":["https://orcid.org/0000-0002-1908-3307"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hagop M. Kantarjian","raw_affiliation_strings":["Department of Leukemia, The University of Texas M.D. Anderson Cancer Center Texas USA"],"raw_orcid":"https://orcid.org/0000-0002-1908-3307","affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas M.D. Anderson Cancer Center Texas USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075400575","display_name":"Katherine P. Hearn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katherine Hearn","raw_affiliation_strings":["Department of Leukemia, The University of Texas M.D. Anderson Cancer Center Texas USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas M.D. Anderson Cancer Center Texas USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084290698","display_name":"Zeev E. Estrov","orcid":"https://orcid.org/0000-0002-1623-3613","observed_orcids":["https://orcid.org/0000-0002-1623-3613"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zeev Estrov","raw_affiliation_strings":["Department of Leukemia, The University of Texas M.D. Anderson Cancer Center Texas USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas M.D. Anderson Cancer Center Texas USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022176722","display_name":"Steven R. Reyes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven Reyes","raw_affiliation_strings":["Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center Texas USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center Texas USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083910226","display_name":"Carlos Bueso-Ramos","orcid":"https://orcid.org/0000-0003-0180-7124","observed_orcids":["https://orcid.org/0000-0003-0180-7124"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carlos E. Bueso\u2010Ramos","raw_affiliation_strings":["Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center Texas USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center Texas USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061026876","display_name":"Guillermo Garcia\u2010Manero","orcid":"https://orcid.org/0000-0002-3631-2482","observed_orcids":["https://orcid.org/0000-0002-3631-2482"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Guillermo Garcia\u2010Manero","raw_affiliation_strings":["Department of Leukemia, The University of Texas M.D. Anderson Cancer Center Texas USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas M.D. Anderson Cancer Center Texas USA","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5061026876"],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":{"value":5450,"currency":"USD","value_usd":5450},"apc_paid":null,"fwci":2.2513,"has_fulltext":true,"cited_by_count":26,"citation_normalized_percentile":{"value":0.88377827,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":98},"biblio":{"volume":"92","issue":"7","first_page":"674","last_page":"682"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9950000047683716},{"id":"https://openalex.org/keywords/nf-kappab-activation","display_name":"NF-\u03baB activation","score":0.8330000042915344},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.7390000224113464},{"id":"https://openalex.org/keywords/subcutaneous-administration","display_name":"subcutaneous administration","score":0.6629999876022339},{"id":"https://openalex.org/keywords/pp65","display_name":"pp65","score":0.6859999895095825},{"id":"https://openalex.org/keywords/ring-sideroblasts","display_name":"ring sideroblasts","score":0.9890000224113464},{"id":"https://openalex.org/keywords/transfusion-dependence","display_name":"transfusion dependence","score":0.6359999775886536},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.6869999766349792},{"id":"https://openalex.org/keywords/hematological-response","display_name":"hematologic response","score":0.5929999947547913},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.6480000019073486},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.41999998688697815}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.827134370803833},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.7593377828598022},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.7501159310340881},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7078403234481812},{"id":"https://openalex.org/C2780240888","wikidata":"https://www.wikidata.org/wiki/Q6052586","display_name":"International Prognostic Scoring System","level":4,"score":0.6720706820487976},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.620546817779541},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5100663304328918},{"id":"https://openalex.org/C2778367456","wikidata":"https://www.wikidata.org/wiki/Q7251235","display_name":"Proteasome inhibitor","level":3,"score":0.5020561218261719},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.47622281312942505},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.45433977246284485},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.43703216314315796},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.35802969336509705},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.15365946292877197},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069286","descriptor_name":"Bortezomib","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000069286","descriptor_name":"Bortezomib","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000069286","descriptor_name":"Bortezomib","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001853","descriptor_name":"Bone Marrow","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002871","descriptor_name":"Chromosome Banding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004252","descriptor_name":"DNA Mutational Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016328","descriptor_name":"NF-kappa B","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1002/ajh.24746","doi":"https://doi.org/10.1002/ajh.24746","is_oa":true,"landing_page_url":"https://doi.org/10.1002/ajh.24746","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ajh.24746","source":{"id":"https://openalex.org/S199810014","display_name":"American Journal of Hematology","issn_l":"0361-8609","issn":["0361-8609","1096-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Hematology","raw_type":"journal-article"},{"id":"pmid:28370157","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28370157","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of hematology","raw_type":"Clinical Trial"},{"id":"pmh:oai:europepmc.org:4975626","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5580683","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5580683","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5580683","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Am J Hematol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1002/ajh.24746","doi":"https://doi.org/10.1002/ajh.24746","is_oa":true,"landing_page_url":"https://doi.org/10.1002/ajh.24746","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ajh.24746","source":{"id":"https://openalex.org/S199810014","display_name":"American Journal of Hematology","issn_l":"0361-8609","issn":["0361-8609","1096-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Hematology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G132965223","display_name":null,"funder_award_id":"#CA16672","funder_id":"https://openalex.org/F4320332521","funder_display_name":"University of Texas MD Anderson Cancer Center"},{"id":"https://openalex.org/G1402313056","display_name":"SPORE University of Texas M. D. Anderson Cancer Center-Leukemia","funder_award_id":"P50CA100632","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G640481018","display_name":null,"funder_award_id":"P30CA 16672","funder_id":"https://openalex.org/F4320332521","funder_display_name":"University of Texas MD Anderson Cancer Center"},{"id":"https://openalex.org/G7251053267","display_name":null,"funder_award_id":"RP141500","funder_id":"https://openalex.org/F4320308129","funder_display_name":"Cancer Prevention and Research Institute of Texas"},{"id":"https://openalex.org/G9000878657","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA016672","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320308129","display_name":"Cancer Prevention and Research Institute of Texas","ror":"https://ror.org/0003xa228"},{"id":"https://openalex.org/F4320310832","display_name":"Edward P. Evans Foundation","ror":"https://ror.org/03h22gm35"},{"id":"https://openalex.org/F4320332521","display_name":"University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07"},{"id":"https://openalex.org/F4320333265","display_name":"Takeda Oncology","ror":"https://ror.org/05vm7p871"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2604932078.pdf","grobid_xml":"https://content.openalex.org/works/W2604932078.grobid-xml"},"referenced_works_count":63,"referenced_works":["https://openalex.org/W187238933","https://openalex.org/W1928159695","https://openalex.org/W1958987550","https://openalex.org/W1966230361","https://openalex.org/W1973465167","https://openalex.org/W1979521298","https://openalex.org/W1983392832","https://openalex.org/W1985275612","https://openalex.org/W1988191177","https://openalex.org/W1988356885","https://openalex.org/W1991753383","https://openalex.org/W1995744610","https://openalex.org/W1997757445","https://openalex.org/W1998351143","https://openalex.org/W2002191849","https://openalex.org/W2002603113","https://openalex.org/W2006699608","https://openalex.org/W2007456673","https://openalex.org/W2009656063","https://openalex.org/W2018711510","https://openalex.org/W2020719716","https://openalex.org/W2024855708","https://openalex.org/W2026042590","https://openalex.org/W2027584688","https://openalex.org/W2038713860","https://openalex.org/W2042073539","https://openalex.org/W2043634641","https://openalex.org/W2053968609","https://openalex.org/W2054891276","https://openalex.org/W2055892514","https://openalex.org/W2071941388","https://openalex.org/W2074725580","https://openalex.org/W2077247713","https://openalex.org/W2083829960","https://openalex.org/W2086048608","https://openalex.org/W2086404440","https://openalex.org/W2091334048","https://openalex.org/W2103885009","https://openalex.org/W2107398329","https://openalex.org/W2107704801","https://openalex.org/W2114925009","https://openalex.org/W2115219209","https://openalex.org/W2121710010","https://openalex.org/W2126448969","https://openalex.org/W2129510594","https://openalex.org/W2130864403","https://openalex.org/W2131095909","https://openalex.org/W2131574772","https://openalex.org/W2134062610","https://openalex.org/W2137374045","https://openalex.org/W2145493193","https://openalex.org/W2154589633","https://openalex.org/W2166043738","https://openalex.org/W2169183166","https://openalex.org/W2206973898","https://openalex.org/W2285540945","https://openalex.org/W2304587401","https://openalex.org/W2326726820","https://openalex.org/W2333006871","https://openalex.org/W2341932560","https://openalex.org/W2438498562","https://openalex.org/W3135020720","https://openalex.org/W4232645703"],"related_works":["https://openalex.org/W4206939708","https://openalex.org/W2517814197","https://openalex.org/W2002603113","https://openalex.org/W2003659766","https://openalex.org/W2979797727","https://openalex.org/W2086048608","https://openalex.org/W2514209409","https://openalex.org/W2160557068","https://openalex.org/W2063005469","https://openalex.org/W2892063324"],"abstract_inverted_index":{"Myelodysplastic":[0],"syndromes":[1],"(MDSs)":[2],"are":[3,17,34],"characterized":[4],"by":[5,103,204],"ineffective":[6],"hematopoiesis":[7],"and":[8,100,123],"an":[9,46],"increased":[10],"risk":[11,21,74],"of":[12,28,68,79,107,128,145,151,167,188,228,234],"transformation.":[13],"Few":[14],"effective":[15],"therapies":[16,109],"available":[18],"for":[19,41],"lower":[20,73],"MDS":[22,31,75],"patients,":[23],"especially":[24],"after":[25],"the":[26,37,146,229,232],"failure":[27],"hypomethylating":[29],"agents.":[30],"progenitor":[32],"cells":[33],"dependent":[35],"on":[36],"nuclear":[38],"factor-\u03baB":[39],"(NF-\u03baB)":[40],"survival,":[42],"which":[43],"makes":[44],"it":[45],"attractive":[47],"therapeutic":[48],"target.":[49],"As":[50],"a":[51,65,159,180,209],"proteosomal":[52],"inhibitor,":[53],"bortezomib":[54,71,133],"is":[55,215],"thought":[56],"to":[57],"have":[58],"inhibitory":[59],"activity":[60],"against":[61],"NF-\u03baB.":[62],"We":[63],"designed":[64],"proof-of-principle":[66],"study":[67,198],"subcutaneous":[69],"(SC)":[70],"in":[72,82,161,164,183,185,212,217,231],"patients":[76,87,113,125,143,170,192],"with":[77,138,153],"evidence":[78,127,150],"NF-\u03baB":[80,201],"activation":[81],"their":[83,90],"bone":[84],"marrow.":[85],"Fifteen":[86],"were":[88,98,114],"treated,":[89],"median":[91,105,118],"age":[92],"was":[93,110,121,134],"71":[94],"(range":[95],"56-87),":[96],"33%":[97],"low":[99],"67%":[101],"int-1":[102],"IPSS,":[104],"number":[106],"prior":[108],"2,":[111],"all":[112],"transfusion":[115],"dependent.":[116],"Baseline":[117],"pp65":[119,162,205],"percentage":[120],"31%":[122],"11":[124],"had":[126,149],"ring":[129],"sideroblasts":[130],"(RS).":[131],"SC":[132],"safe,":[135],"well":[136],"tolerated":[137],"no":[139],"excess":[140],"toxicity.":[141],"Three":[142],"out":[144,166,187],"15":[147],"(20%)":[148],"response":[152],"hematologic":[154],"improvement":[155],"(HI-E).":[156],"Bortezomib":[157,214],"caused":[158],"decrease":[160,182],"levels":[163],"7":[165,186],"13":[168],"evaluable":[169,191],"(54%,":[171],"P":[172],"=":[173],".025).":[174],"Of":[175],"interest,":[176],"unexpectedly,":[177],"we":[178],"observed":[179],"significant":[181],"RS":[184,235],"10":[189],"(70%)":[190],"during":[193],"treatment.":[194],"In":[195],"conclusion,":[196],"this":[197,218],"suggests":[199],"that":[200],"activation,":[202],"measured":[203],"levels,":[206],"may":[207],"be":[208],"useful":[210],"biomarker":[211],"MDS.":[213],"safe":[216],"patient":[219],"population":[220],"but":[221],"has":[222],"modest":[223],"clinical":[224],"activity.":[225],"The":[226],"role":[227],"proteasome":[230],"genesis":[233],"needs":[236],"further":[237],"study.":[238]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-04-14T00:00:00"}